Pharmacists in Grand Saline, TX Accepting Medicare
3 Pharmacists found. Showing 1 - 3
 Michael Lee Green, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 W Frank St, Grand Saline, TX 75140 Phone: 903-962-4063 Fax: 903-962-4270 |
 Ms. Janelle Marie Betts, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 W Frank St, Grand Saline, TX 75140 Phone: 903-962-4063 Fax: 866-544-4246 |
Megan Isabelle Richards, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 W Frank St, Grand Saline, TX 75140 Phone: 903-962-4063 |
News Archive
Doubt cast over study that says milk linked to ovarian cancer
Swedish researchers say that drinking just one glass of milk a day may increase the risk of women developing ovarian cancer.
Combination therapy improves patients with depression symptoms: Study
New data presented today at the American Psychiatric Association's annual meeting suggests a benefit to combining L-methylfolate, a prescription medical food called Deplin, with an antidepressant at the start of treatment. This retrospective analysis showed a significantly greater improvement in depression symptoms in a shorter period of time, when patients with Major Depressive Disorder were started on combination therapy.
Tips for how to help someone with PTSD
You don't have to be a member of the armed forces to have post-traumatic stress disorder (PTSD), but nearly 20 percent of service members deployed to Iraq and Afghanistan reported having symptoms. In recognition of June as PTSD Awareness Month, Wounded Warrior Project (WWP) is offering 10 tips for how to help someone who may be suffering from PTSD.
Artificial intelligence helps identify new key-lock pairs against coronavirus
The human immune defense is based on the ability of white blood cells to accurately identify disease-causing pathogens and to initiate a defense reaction against them.
Nanotherapeutics files INDA for NanoDOX hydrogel to treat type of diabetic ulcers
Nanotherapeutics announced today that it has submitted its first Investigational New Drug (IND) application to the FDA for a phase IIa clinical study for its product NanoDOX Hydrogel, a topical doxycycline hydrogel for chronic wounds.
› Verified 7 days ago